Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours
Christian FlugelBIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health (BIH) at Charité-Universitätsmedizin Berlin, Berlin, GermanyRobbie G. MajznerDepartment of Paediatrics, Stanford University School of Medicine, Stanford, CA, USAGiedre KrenciuteDepartment of Bone Marrow Transplantation and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN, USAGianpietro DottiDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USAStanley R. RiddellDepartment of Medicine University of Washington, Seattle, WA, USADimitrios L. WagnerBIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health (BIH) at Charité-Universitätsmedizin Berlin, Berlin, GermanyMohamed Abou‐El‐EneinDepartment of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. [email protected]
2022en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba